概括
维拉帕米尔在患有高血压的黑人和白人患者中有效降低血压 (BP),表现优于普罗兰诺洛. 这项研究强调了维拉帕米尔作为一种安全有效的单一疗法,用于管理基本高血压.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 高血压研究 高血压研究
背景情况:
- 基本高血压是一种广泛的疾病,需要有效的单一治疗.
- 对比不同抗高血压药物的有效性和安全性对于最佳的患者护理至关重要.
- 维拉帕米尔和甲醇化物是用于高血压管理的已知药物.
研究的目的:
- 为了比较维拉帕米尔与甲醇化物作为基本高血压单一治疗的疗效.
- 评估不同种族群体 (黑人和白人患者) 的治疗有效性.
- 评估维拉帕米尔和普拉诺洛尔的安全性和副作用.
主要方法:
- 一项涉及患有基本高血压的患者的比较研究.
- 用维拉帕米尔或罗醇化物进行单一治疗.
- 监测血压 (BP),心率,PR间隔和不良事件.
主要成果:
- 维拉帕米尔在黑人和白人患者中表现出优异的血压降低,与普罗普兰诺洛尔相比.
- 维拉帕米尔在黑人和白人患者中同样有效,而普罗普拉诺洛尔在白人患者中更有效.
- 维拉帕米尔的发病率较低,血压升高,并较少的不良反应,如疲劳和头,与普罗普兰诺洛尔相比.
结论:
- 维拉帕米尔单一疗法是一种安全有效的治疗方法,用于在患有基本高血压的患者中实现血压控制.
- 与propranolol相比,维拉帕米尔在不同种族群体中提供了更一致的血压降低效果.
- 维拉帕米尔在高血压管理方面具有有利的安全性,并具有可控的副作用.
相关概念视频
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...


